---
title: "12 Health Care Stocks Moving In Tuesday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299049191.md"
description: "In Tuesday's pre-market session, several healthcare stocks showed significant movement. Gainers included Biodexa Pharmaceuticals (up 39.3%), Vera Therapeutics (up 14.53%), and Akari Therapeutics (up 14.31%). Conversely, losers featured Connect Biopharma Holdings (down 36.2%) and Scinai Immunotherapeutics (down 23.78%). These fluctuations occurred ahead of regular trading hours."
datetime: "2026-09-15T12:05:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299049191.md)
  - [en](https://longbridge.com/en/news/299049191.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299049191.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

### Gainers

-   **Biodexa Pharmaceuticals** (NASDAQ:BDRX) shares moved upwards by 39.3% to $1.56 during Tuesday's pre-market session. The company's market cap stands at $1.1 million. As per the press release, H1 earnings came out 2 days ago.
-   **Vera Therapeutics** (NASDAQ:VERA) stock increased by 14.53% to $39.0. The company's market cap stands at $2.4 billion.
-   **Akari Therapeutics** (NASDAQ:AKTX) shares moved upwards by 14.31% to $12.62. The company's market cap stands at $21.4 million.
-   **Waystar Holding** (NASDAQ:WAY) shares rose 12.65% to $28.05. The market value of their outstanding shares is at $4.7 billion.
-   **PDS Biotechnology** (NASDAQ:PDSB) shares rose 11.92% to $0.45. The company's market cap stands at $22.3 million.
-   **Tenon Medical** (NASDAQ:TNON) stock moved upwards by 11.33% to $6.19. The market value of their outstanding shares is at $3.7 million.

### Losers

-   **Connect Biopharma Hldgs** (NASDAQ:CNTB) shares declined by 36.2% to $1.1 during Tuesday's pre-market session. The company's market cap stands at $108.6 million.
-   **Scinai Immunotherapeutics** (NASDAQ:SCNI) shares declined by 23.78% to $1.86. The company's market cap stands at $1.6 million.
-   **Q/C Technologies** (NASDAQ:QCLS) stock fell 17.59% to $0.46. The market value of their outstanding shares is at $4.5 million.
-   **Basel Medical Group** (NASDAQ:BMGL) stock declined by 14.57% to $6.1. The market value of their outstanding shares is at $11.1 million.
-   **Silexion Therapeutics** (NASDAQ:SLXN) shares fell 13.78% to $0.33. The company's market cap stands at $2.1 million.
-   **EUDA Health Holdings** (NASDAQ:EUDA) shares fell 12.44% to $14.5. The company's market cap stands at $49.5 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [BDRX.US](https://longbridge.com/en/quote/BDRX.US.md)
- [SCNI.US](https://longbridge.com/en/quote/SCNI.US.md)
- [VERA.US](https://longbridge.com/en/quote/VERA.US.md)
- [AKTX.US](https://longbridge.com/en/quote/AKTX.US.md)
- [CNTB.US](https://longbridge.com/en/quote/CNTB.US.md)
- [WAY.US](https://longbridge.com/en/quote/WAY.US.md)
- [PDSB.US](https://longbridge.com/en/quote/PDSB.US.md)
- [TNON.US](https://longbridge.com/en/quote/TNON.US.md)
- [QCLS.US](https://longbridge.com/en/quote/QCLS.US.md)
- [BMGL.US](https://longbridge.com/en/quote/BMGL.US.md)
- [SLXN.US](https://longbridge.com/en/quote/SLXN.US.md)
- [EUDA.US](https://longbridge.com/en/quote/EUDA.US.md)
- [TNONW.US](https://longbridge.com/en/quote/TNONW.US.md)
- [SLXNW.US](https://longbridge.com/en/quote/SLXNW.US.md)
- [EUDAW.US](https://longbridge.com/en/quote/EUDAW.US.md)

## Related News & Research

- [Guggenheim Reaffirms Their Buy Rating on Vera Therapeutics (VERA)](https://longbridge.com/en/news/302878937.md)
- [Vera Therapeutics' TRUTAKNA Delivers Strong Phase III IgA Nephropathy Results](https://longbridge.com/en/news/302795418.md)
- [Akari Therapeutics grants director Bazemore restricted stock units in lieu of unpaid cash retainers](https://longbridge.com/en/news/302148115.md)
- [Scinai Immunotherapeutics Ltd. (SCNI) Secures $5.1M CDMO Work, Runway to Late 2027](https://longbridge.com/en/news/302424934.md)
- [Scinai Immunotherapeutics Extends Cash Runway on New CDMO Deal and October Financing](https://longbridge.com/en/news/302438355.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**